IFIH1杂合变异与以肺部为主受累的间质性肺病表型
在559例接受外显子测序的间质性肺病患儿中鉴定出12个罕见IFIH1杂合变异,其中4个变异经体外荧光素酶试验和ISG表达谱证实为功能获得性(GoF)。携带强GoF变异的两例患儿多系统受累并于3月龄和4月龄死于呼吸衰竭,另两例慢性肺病分别于8岁和10岁稳定。肺活检示肺泡发育不良及脱屑性间质性肺炎。
要点
- IFIH1 GoF变异可表现为以间质性肺病为主的表型,扩展了I型干扰素病的肺部受累谱。
- 疾病严重程度与变异的GoF活性相关,强GoF者可致婴儿期多系统受累并死于呼吸衰竭。
- 肺活检可见肺泡发育不良和不同程度脱屑性间质性肺炎。
核心结论
- 携带新型IFIH1变异的个体可表现以间质性肺病为主的显性遗传表型,将IFIH1相关疾病扩展至具有肺部表现的I型干扰素病范畴。
研究设计与样本
- 在559例接受外显子测序作为诊断评估的间质性肺病患儿中鉴定出12个罕见IFIH1杂合变异。
- 对10个意义未明的错义变异采用荧光素酶试验和ISG表达谱进行体外功能评估,并对可获得的患者样本行全基因组RNA分析。
主要发现
- 4个变异在体外显示基础IFNβ转录增加、体内ISG表达升高,提示功能获得性(GoF)行为。
- 疾病严重程度与相应变异的GoF潜力相关。
- 两例携带强GoF活性IFIH1变异的患者有多系统受累,分别于3月龄和4月龄死于呼吸衰竭。
- 另两例患者表型较轻,慢性肺病分别于8岁和10岁稳定。
- 肺活检显示肺泡发育不良及不同程度脱屑性间质性肺炎(肺泡巨噬细胞肺炎)。
临床怎么用
- 对儿童间质性肺病,尤其伴多系统受累或婴儿期重症呼吸衰竭者,应考虑IFIH1相关I型干扰素病的可能。
- 变异功能学评估(体外IFNβ转录与ISG表达)有助于判断GoF活性并与疾病严重程度关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heterozygous gain-of-function (GoF) variants in IFIH1 are associated with rare autoinflammatory diseases characterized by heightened interferons-stimulated gene (ISG) signatures. These include Aicardi-Goutières syndrome, presenting with slowly progressive spastic paraparesis of the lower limbs, intracerebral calcifications, and neuroinflammation, and Singleton-Merten syndrome, defined by tooth loss, bone demineralization, and vascular calcification. RESEARCH QUESTION: Do rare IFIH1 GoF variants contribute to an interstitial lung disease phenotype, thereby expanding the spectrum of IFIH1-related disorders? STUDY DESIGN AND METHODS: Among 559 children with interstitial lung disease (chILD) and exome sequencing as part of their diagnostic work-up, 12 rare heterozygous IFIH1 variants were identified. Of these, 10 were missense variants of unknown significance, which were functionally assessed in vitro using luciferase assay and ISG-expression profiling. Genome-wide RNA analysis was performed on available patient samples to explore broader transcriptional effects. RESULTS: Four variants with increased basal IFNβ transcription in vitro and elevated ISG expression in vivo indicating GoF behaviour were identified. Disease severity correlated with GoF potential of the respective variant. Two patients harbouring IFIH1 variants with strong GoF activity displayed multisystem involvement and died from respiratory failure at 3 and 4 months of age, respectively. Two additional patients showed milder phenotypes with chronic lung disease stabilizing by the age of 8 and 10 years, respectively. Lung biopsies showed alveolar hypoplasia and alveolar macrophage pneumonia (=desquamative interstitial pneumonia) of varying severity. INTERPRETATION: We report a dominant interstitial lung disease phenotype in individuals harbouring novel IFIH1 variants, expanding IFIH1-related disease to the group of type I interferonopathies with pulmonary manifestations like STING-associated vasculopathy with onset in infancy (SAVI) and COPA syndrome.
引用
- Rapp CK, Herkner M, Crippa VSE, et al. Dominant lung involvement and heterozygous IFIH1 variants. Chest. 2026. PMID: 42863753. doi:10.1016/j.chest.2026.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。